VALENTINO, Paola
VALENTINO, Paola
SCIENZE CLINICHE E BIOLOGICHE
Anti-interferon-β neutralising activity is not entirely mediated by antibodies
2007-01-01 Gilli F.; Marnetto F.; Caldano M.; Valentino P.; Granieri L.; Di Sapio A.; Capobianco M.; Sala A.; Malucchi S.; Kappos L.; Lindberg R.L.P.; Bertolotto A.
Aquaporin-4 antibody titration in NMO patients treated with rituximab: A retrospective study
2017-01-01 Valentino P.; Marnetto F.; Granieri L.; Capobianco M.; Bertolotto A.
Biological monitoring of IFN-β therapy in Multiple Sclerosis
2015-01-01 Bertolotto A.; Granieri L.; Marnetto F.; Valentino P.; Sala A.; Capobianco M.; Malucchi S.; Di Sapio A.; Malentacchi M.; Matta M.; Caldano M.
CD19 mRNA quantification improves rituximab treatment-to-target approach: A proof of concept study
2014-01-01 Marnetto F.; Granieri L.; Valentino P.; Capobianco M.; Pautasso M.; Bertolotto A.
Cerebrospinal fluid neurofilament light chains predicts early disease-activity in Multiple Sclerosis
2023-01-01 Toscano S.; Oteri V.; Chisari C.G.; Finocchiaro C.; Lo Fermo S.; Valentino P.; Bertolotto A.; Zappia M.; Patti F.
Classification of individuals based on ex-vivo glatiramer acetate-induced interferon-γ and interleukin-4 response
2012-01-01 Gilli F.; Navone N.D.; Valentino P.; Granieri L.; Perga S.; Malucchi S.; Bertolotto A.
Cytomegalovirus, Epstein-Barr Virus, Herpes Simplex Virus, and Varicella Zoster Virus Infection Dynamics in People with Multiple Sclerosis from Northern Italy
2024-01-01 Peter A. Maple; Radu Tanasescu; Cris S. Constantinescu; Paola Valentino; Marco Capobianco; Silvia D'Orso; Giovanna Borsellino; Luca Battistini; Giovanni Ristori; Rosella Mechelli; Marco Salvetti; Bruno Gran
Detection of potassium channel KIR4.1 antibodies in Multiple Sclerosis patients
2017-01-01 Marnetto F.; Valentino P.; Caldano M.; Bertolotto A.
Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serology
2012-01-01 Granieri L.; Marnetto F.; Valentino P.; Frau J.; Patanella A.K.; Nytrova P.; Sola P.; Capobianco M.; Jarius S.; Bertolotto A.
Expression and regulation of IFNα/β receptor in IFNβ-treated patients with multiple sclerosis
2008-01-01 Gilli F.; Valentino P.; Caldano M.; Granieri L.; Capobianco M.; Malucchi S.; Sala A.; Marnetto F.; Bertolotto A.
Hepatic expression of hemochromatosis genes in two mouse strains after phlebotomy and iron overload.
2005-01-01 Bondi A;Valentino P;Daraio F;Porporato P;Gramaglia E;Carturan S;Gottardi E;Camaschella C;Roetto A
In multiple sclerosis patients a single serum neurofilament light chain (sNFL) dosage is strongly associated with 12 months outcome: data from a real-life clinical setting
2024-01-01 Malucchi S.; Bava C.I.; Valentino P.; Martire S.; Lo Re M.; Bertolotto A.; Di Sapio A.
Learning from nature: pregnancy changes the expression of inflammation-related genes in patients with multiple sclerosis.
2010-01-01 Gilli F; Lindberg RL; Valentino P; Marnetto F; Malucchi S; Sala A; Capobianco M; di Sapio A; Sperli F; Kappos L; Calogero RA; Bertolotto A.
Predictive markers for response to interferon therapy in patients with multiple sclerosis
2008-01-01 Malucchi S.; Gilli F.; Caldano M.; Marnetto F.; Valentino P.; Granieri L.; Sala A.; Capobianco M.; Bertolotto A.
Prevalence of elevated sNFL in a real-world setting: Results on 908 patients with different multiple sclerosis types and treatment conditions
2024-01-01 Bava, Cecilia Irene; Valentino, Paola; Malucchi, Simona; Bottero, Rugiada; Martire, Serena; Sapio, Alessia Di; Bertolotto, Antonio
Qualitative and quantitative analysis of antibody response against IFNβ in patients with multiple sclerosis
2006-01-01 Gilli F.; Hoffmann F.; Sala A.; Marnetto F.; Caladno M.; Valentino P.; Kappos L.; Bertolotto A.; Lindberg R.L.P.
Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders
2018-01-01 Andrea Marcinnò; Fabiana Marnetto; Paola Valentino; Serena Martire; Alessia Balbo; Aurora Drago; Maria Leto; Marco Capobianco; Giancarlo Panzica; Antonio Bertolotto
Serum and cerebrospinal fluid neurofilament light chains measured by SIMOA™, Ella™, and Lumipulse™ in multiple sclerosis naïve patients
2024-01-01 Vecchio D.; Puricelli C.; Malucchi S.; Virgilio E.; Martire S.; Perga S.; Passarelli F.; Valentino P.; Di Sapio A.; Cantello R.; Dianzani U.; Comi C.
Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder
2024-01-01 Carta, Sara; Dinoto, Alessandro; Capobianco, Marco; Valentino, Paola; Montarolo, Francesca; Sala, Arianna; Reindl, Markus; Lo Re, Marianna; Chiodega, Vanessa; Branger, Pierre; Audoin, Bertrand; Aboab, Jennifer; Papeix, Caroline; Collongues, Nicolas; Kerschen, Philippe; Zephir, Helene; Créange, Alain; Bourre, Bertrand; Schanda, Kathrin; Flanagan, Eoin P; Redenbaugh, Vyanka; Villacieros-Álvarez, Javier; Arrambide, Georgina; Cobo-Calvo, Alvaro; Ferrari, Sergio; Marignier, Romain; Mariotto, Sara
Serum neurofilament light chain levels in healthy individuals: A proposal of cut-off values for use in multiple sclerosis clinical practice
2021-01-01 Valentino P.; Marnetto F.; Martire S.; Malucchi S.; Bava C.I.; Popovic M.; Bertolotto A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Anti-interferon-β neutralising activity is not entirely mediated by antibodies | 2007 | Gilli F.; Marnetto F.; Caldano M.; Valentino P.; Granieri L.; Di Sapio A.; Capobianco M.; Sala A.; Malucchi S.; Kappos L.; Lindberg R.L.P.; Bertolotto A. | |
| Aquaporin-4 antibody titration in NMO patients treated with rituximab: A retrospective study | 2017 | Valentino P.; Marnetto F.; Granieri L.; Capobianco M.; Bertolotto A. | |
| Biological monitoring of IFN-β therapy in Multiple Sclerosis | 2015 | Bertolotto A.; Granieri L.; Marnetto F.; Valentino P.; Sala A.; Capobianco M.; Malucchi S.; Di Sapio A.; Malentacchi M.; Matta M.; Caldano M. | |
| CD19 mRNA quantification improves rituximab treatment-to-target approach: A proof of concept study | 2014 | Marnetto F.; Granieri L.; Valentino P.; Capobianco M.; Pautasso M.; Bertolotto A. | |
| Cerebrospinal fluid neurofilament light chains predicts early disease-activity in Multiple Sclerosis | 2023 | Toscano S.; Oteri V.; Chisari C.G.; Finocchiaro C.; Lo Fermo S.; Valentino P.; Bertolotto A.; Zappia M.; Patti F. | |
| Classification of individuals based on ex-vivo glatiramer acetate-induced interferon-γ and interleukin-4 response | 2012 | Gilli F.; Navone N.D.; Valentino P.; Granieri L.; Perga S.; Malucchi S.; Bertolotto A. | |
| Cytomegalovirus, Epstein-Barr Virus, Herpes Simplex Virus, and Varicella Zoster Virus Infection Dynamics in People with Multiple Sclerosis from Northern Italy | 2024 | Peter A. Maple; Radu Tanasescu; Cris S. Constantinescu; Paola Valentino; Marco Capobianco; Silvia D'Orso; Giovanna Borsellino; Luca Battistini; Giovanni Ristori; Rosella Mechelli; Marco Salvetti; Bruno Gran | |
| Detection of potassium channel KIR4.1 antibodies in Multiple Sclerosis patients | 2017 | Marnetto F.; Valentino P.; Caldano M.; Bertolotto A. | |
| Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serology | 2012 | Granieri L.; Marnetto F.; Valentino P.; Frau J.; Patanella A.K.; Nytrova P.; Sola P.; Capobianco M.; Jarius S.; Bertolotto A. | |
| Expression and regulation of IFNα/β receptor in IFNβ-treated patients with multiple sclerosis | 2008 | Gilli F.; Valentino P.; Caldano M.; Granieri L.; Capobianco M.; Malucchi S.; Sala A.; Marnetto F.; Bertolotto A. | |
| Hepatic expression of hemochromatosis genes in two mouse strains after phlebotomy and iron overload. | 2005 | Bondi A;Valentino P;Daraio F;Porporato P;Gramaglia E;Carturan S;Gottardi E;Camaschella C;Roetto A | |
| In multiple sclerosis patients a single serum neurofilament light chain (sNFL) dosage is strongly associated with 12 months outcome: data from a real-life clinical setting | 2024 | Malucchi S.; Bava C.I.; Valentino P.; Martire S.; Lo Re M.; Bertolotto A.; Di Sapio A. | |
| Learning from nature: pregnancy changes the expression of inflammation-related genes in patients with multiple sclerosis. | 2010 | Gilli F; Lindberg RL; Valentino P; Marnetto F; Malucchi S; Sala A; Capobianco M; di Sapio A; Sperli F; Kappos L; Calogero RA; Bertolotto A. | |
| Predictive markers for response to interferon therapy in patients with multiple sclerosis | 2008 | Malucchi S.; Gilli F.; Caldano M.; Marnetto F.; Valentino P.; Granieri L.; Sala A.; Capobianco M.; Bertolotto A. | |
| Prevalence of elevated sNFL in a real-world setting: Results on 908 patients with different multiple sclerosis types and treatment conditions | 2024 | Bava, Cecilia Irene; Valentino, Paola; Malucchi, Simona; Bottero, Rugiada; Martire, Serena; Sapio, Alessia Di; Bertolotto, Antonio | |
| Qualitative and quantitative analysis of antibody response against IFNβ in patients with multiple sclerosis | 2006 | Gilli F.; Hoffmann F.; Sala A.; Marnetto F.; Caladno M.; Valentino P.; Kappos L.; Bertolotto A.; Lindberg R.L.P. | |
| Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders | 2018 | Andrea Marcinnò; Fabiana Marnetto; Paola Valentino; Serena Martire; Alessia Balbo; Aurora Drago; Maria Leto; Marco Capobianco; Giancarlo Panzica; Antonio Bertolotto | |
| Serum and cerebrospinal fluid neurofilament light chains measured by SIMOA™, Ella™, and Lumipulse™ in multiple sclerosis naïve patients | 2024 | Vecchio D.; Puricelli C.; Malucchi S.; Virgilio E.; Martire S.; Perga S.; Passarelli F.; Valentino P.; Di Sapio A.; Cantello R.; Dianzani U.; Comi C. | |
| Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder | 2024 | Carta, Sara; Dinoto, Alessandro; Capobianco, Marco; Valentino, Paola; Montarolo, Francesca; Sala, Arianna; Reindl, Markus; Lo Re, Marianna; Chiodega, Vanessa; Branger, Pierre; Audoin, Bertrand; Aboab, Jennifer; Papeix, Caroline; Collongues, Nicolas; Kerschen, Philippe; Zephir, Helene; Créange, Alain; Bourre, Bertrand; Schanda, Kathrin; Flanagan, Eoin P; Redenbaugh, Vyanka; Villacieros-Álvarez, Javier; Arrambide, Georgina; Cobo-Calvo, Alvaro; Ferrari, Sergio; Marignier, Romain; Mariotto, Sara | |
| Serum neurofilament light chain levels in healthy individuals: A proposal of cut-off values for use in multiple sclerosis clinical practice | 2021 | Valentino P.; Marnetto F.; Martire S.; Malucchi S.; Bava C.I.; Popovic M.; Bertolotto A. |